Literature DB >> 21271614

Successful treatment of IgG and complement-mediated autoimmune hemolytic anemia with bortezomib and low-dose cyclophosphamide.

Pongwut Danchaivijitr, Jean Yared, Aaron P Rapoport.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21271614     DOI: 10.1002/ajh.21950

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

Review 1.  Development of New Drugs for Autoimmune Hemolytic Anemia.

Authors:  Zhengrui Xiao; Irina Murakhovskaya
Journal:  Pharmaceutics       Date:  2022-05-11       Impact factor: 6.525

Review 2.  New frontiers in pediatric Allo-SCT.

Authors:  J M Talano; M A Pulsipher; H J Symons; O Militano; E B Shereck; R H Giller; L Hancock; E Morris; M S Cairo
Journal:  Bone Marrow Transplant       Date:  2014-05-12       Impact factor: 5.483

Review 3.  B cells in autoimmune hepatitis: bystanders or central players?

Authors:  Christoph Schultheiß; Silja Steinmann; Ansgar W Lohse; Mascha Binder
Journal:  Semin Immunopathol       Date:  2022-04-29       Impact factor: 11.759

4.  Characterization of a novel hemolytic activity of human IgG fractions arising from diversity in protein and oligosaccharide components.

Authors:  Shaoying Min; Fang Yan; Yueling Zhang; Xiangqun Ye; Mingqi Zhong; Jinsong Cao; Haiying Zou; Jiehui Chen
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

Review 5.  Targeting B Cells and Plasma Cells in Autoimmune Diseases.

Authors:  Katharina Hofmann; Ann-Katrin Clauder; Rudolf Armin Manz
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

6.  Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives.

Authors:  Wilma Barcellini; Bruno Fattizzo; Anna Zaninoni
Journal:  J Blood Med       Date:  2019-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.